As of June 15, 2025, Wattana Karnpaet PCL (NEW.BK) reports a Gross Margin of 22.80%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Wattana Karnpaet PCL's Gross Margin
Over recent years, Wattana Karnpaet PCL's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 22.80% |
| 2023-12-31 | 26.20% |
| 2022-12-31 | 35.76% |
| 2021-12-31 | 21.57% |
| 2020-12-31 | 21.61% |
This slight downward trend highlights how Wattana Karnpaet PCL manages its operational efficiency and pricing power over time.
Comparing Wattana Karnpaet PCL's Gross Margin to Peers
To better understand Wattana Karnpaet PCL's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Wattana Karnpaet PCL (NEW.BK) | 22.80% |
| Tejnaksh Healthcare Ltd (539428.BO) | 90.02% |
| Fortis Malar Hospitals Ltd (523696.BO) | 85.14% |
| Chennai Meenakshi Multispeciality Hospital Ltd (523489.BO) | 81.24% |
| Bumrungrad Hospital PCL (BH.BK) | 51.23% |
| Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) | 49.75% |
Compared to its competitors, Wattana Karnpaet PCL's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.